Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
10/03/2013 | WO2013147561A1 Pharmaceutical compositions comprising an extract from smilax china linne for preventing or treating obesity, hyperlipidemia or fatty liver |
10/03/2013 | WO2013147026A1 Aromatic ring compound |
10/03/2013 | WO2013146911A1 Prophylactic or therapeutic agent for diabetes |
10/03/2013 | WO2013146891A1 Subcutaneous fat accumulation inhibitor |
10/03/2013 | WO2013146754A1 Aromatic heterocyclic five-membered ring derivative having trpv4 inhibitory activity |
10/03/2013 | WO2013146539A1 Ppars agonist activity enhancing drug |
10/03/2013 | WO2013146319A1 Diabetes-inducible bacterium |
10/03/2013 | WO2013144273A1 Basal insulin therapy |
10/03/2013 | WO2013144098A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists |
10/03/2013 | WO2013144097A1 New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists |
10/03/2013 | WO2013114403A8 Substituted 4,5-dihydro-2h-benzo[e]indazole-9-carboxylates for the treatment of diabetes and related disorders |
10/03/2013 | WO2013006486A3 Compositions, uses and methods for treatment of metabolic disorders and diseases |
10/03/2013 | US20130259901 Neuropeptide Y Treatment of Autoimmune Disease |
10/02/2013 | EP2644040A1 Condiments with rebaudioside A and erythritol |
10/02/2013 | EP2643311A1 Bicyclic gpr119 modulators |
10/02/2013 | EP2643310A1 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as gpr 119 modulators |
10/02/2013 | EP2643305A1 Multicomponent system of rosuvastatin calcium salt and sorbitol |
10/02/2013 | EP2643290A1 Calcium-sensing receptor-active compounds |
10/02/2013 | EP2642988A1 Method and composition for weight-gain management |
10/02/2013 | CN103339150A Anti-bradykinin B2 receptor (BKB2R) monoclonal antibody |
10/02/2013 | CN103339117A 1,4 oxazines as bace1 and/or bace2 inhibitors |
10/02/2013 | CN103338790A Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient |
10/02/2013 | CN103338789A Pharmaceutical composition containing drug having poor water solubility |
10/02/2013 | CN103338784A Methods for increasing intracellular activity of Hsp70 |
10/02/2013 | CN103338777A Cholesterol level-lowering agent, triglyceride level-lowering agent, blood sugar level-lowering agent, cholesterol adsorbent, adsorbent, triglyceride adsorbent, health food, health supplement, food with nutrient function claims, food for specified he |
10/02/2013 | CN103338762A Suppressor for increase in blood glucose level |
10/02/2013 | CN103338760A Vasoprotective and cardioprotective antidiabetic therapy |
10/02/2013 | CN103338759A 芳香化酶活化剂 Aromatase activator |
10/02/2013 | CN103333941A High purity cerebrolysin vial injection preparation agent |
10/02/2013 | CN103333847A Lactobacillus fermenti grx08 with function of assisting blood fat reduction and application of lactobacillus fermenti grx08 |
10/02/2013 | CN103333773A Mulberry fruit vinegar and preparation method thereof |
10/02/2013 | CN103333245A Anti-cell-acceptor and anti-tumor-growth drug molecule, preparation method thereof and applications thereof |
10/02/2013 | CN103333238A mPEG-MAL-aGLP-1 composite |
10/02/2013 | CN103333223A A novel blood-glucose-reducing polypeptide and applications thereof |
10/02/2013 | CN103333179A Maytansinoid derivatives, preparation method thereof and applications thereof |
10/02/2013 | CN103333161A Preparation method and use of 1'-oxo-indirubin |
10/02/2013 | CN103330939A Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener |
10/02/2013 | CN103330866A Diabetes treatment Chinese patent medicine and production method thereof |
10/02/2013 | CN103330844A Traditional Chinese medicine composition for treating diabetes mellitus |
10/02/2013 | CN103330836A Traditional Chinese medicine composition for treating diabetes mellitus, and application of traditional Chinese medicine composition |
10/02/2013 | CN103330797A Medicament used for treating hypertension and hyperlipidemia, and preparation method thereof |
10/02/2013 | CN103330762A Hawthorn leaf total flavone ordinary-release pellet preparation and preparation method thereof |
10/02/2013 | CN103330741A Japanese pagodatree twig injection |
10/02/2013 | CN103330739A Traditional Chinese medicine compound for improving symptom of diabetes |
10/02/2013 | CN103330734A Medium/long-chain fat emulsion injection pharmaceutical composition and preparation method thereof |
10/02/2013 | CN103330719A Kangaroo bone extract and extraction method thereof |
10/02/2013 | CN103330718A Preparation method of gynostemma pentaphyllum polysaccharide-iron complex |
10/02/2013 | CN103330716A Preparation method of trivitamins B tablets |
10/02/2013 | CN103330703A Method of inhibiting remnant lipoprotein production |
10/02/2013 | CN103330701A Applications of alkylaryl ketone |
10/02/2013 | CN103330693A Simvastatin component improving disintegration and preparation method thereof |
10/02/2013 | CN103330692A Simvastatin component improving stability and preparation method thereof |
10/02/2013 | CN103330691A Simvastatin component improving hardness and preparation method thereof |
10/02/2013 | CN103330681A Glucose injection in inner bag of unsterilized multi-chamber infusion bag and preparation method thereof |
10/02/2013 | CN103330209A Pure traditional Chinese medicine health food assisting in reducing blood sugar and preparation method of pure traditional Chinese medicine health food |
10/02/2013 | CN103330119A Health-care food for accessorily reducing blood fat |
10/02/2013 | CN102920664B Preparation method of long-term oral insulin sustained-release microspheres |
10/02/2013 | CN102895492B Drug for treating hyperlipidaemia |
10/02/2013 | CN102670661B Drug for stimulating glucagon-like peptide 1 (GLP-1) secretion |
10/02/2013 | CN102626440B Traditional Chinese medicine composition for protecting liver and regulating blood fat |
10/02/2013 | CN102600102B Ball bladder of dry ice defatting pill |
10/02/2013 | CN102511568B Fat adjusting hypnotic health care oil |
10/02/2013 | CN102429977B Medicine for treating diabetes |
10/02/2013 | CN102335204B Chinese medicine Jinshuibao pill preparation and preparation method thereof |
10/02/2013 | CN102266520B Traditional Chinese medicine composition for treating diabetes |
10/02/2013 | CN102186364B Concentrated liquid diet |
10/02/2013 | CN102068557B Application of Pu'er tea extract in preparation of medicines for reducing blood fat |
10/02/2013 | CN101983721B Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement |
10/02/2013 | CN101961425B Pu'er tea extract and preparation method and application thereof |
10/01/2013 | US8546429 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
10/01/2013 | US8546379 5HT2C receptor modulators |
10/01/2013 | US8545843 Treatment of vasculitis |
10/01/2013 | US8545833 Treatment of radiation injury using placental stem cells |
10/01/2013 | CA2776407C Method of preparing sitagliptin and intermediates used therein |
10/01/2013 | CA2644848C Compositions and methods for enhancing the antioxidant status of animals |
10/01/2013 | CA2633374C Amine compound and use thereof for medical purposes |
10/01/2013 | CA2624929C Antiobesity composition |
10/01/2013 | CA2624909C Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease |
10/01/2013 | CA2563533C Compositions capable of facilitating penetration across a biological barrier |
10/01/2013 | CA2532152C Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
10/01/2013 | CA2512133C Compositions of arachidonic acid for preventing or alleviating symptoms or diseases due to aging of blood vessels |
10/01/2013 | CA2467689C Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase |
09/30/2013 | CA2810732A1 Compositions and method for improving endothelial function and cardiovascular health |
09/26/2013 | WO2013142816A1 Compounds and compositions for the treatment of muscular disorders |
09/26/2013 | WO2013139695A1 Compositions comprising a delivery agent and preparation thereof |
09/26/2013 | WO2013139694A1 Compositions of glp-1 peptides and preparation thereof |
09/26/2013 | WO2013139341A1 Gpr120 receptor modulators |
09/26/2013 | WO2013139292A1 Joint product containing synephrine and topiramate |
09/26/2013 | WO2013139274A1 Sodium pyruvate oral rehydration salt composition for treating hypovolemia or hyponatration associated with hypohydration |
09/26/2013 | WO2013139209A1 Topiramate sustained-release pharmaceutical composition, method for preparing same, and use thereof |
09/26/2013 | WO2013138964A1 Application of iso-daphnetin compound in preparation of anti-diabetic medicines |
09/26/2013 | WO2013138951A1 Quinazoline derivate and use thereof as apoptosis inhibitor |
09/26/2013 | WO2013072390A3 Stilbene compounds as ppar beta/delta inhibitors for treating ppar beta/delta transmitted illnesses |
09/26/2013 | WO2012121423A8 Pharmaceutical composition for preventing and treating complications of diabetes containing a traditional oriental medicine extract or a fraction thereof as an active ingredient |
09/25/2013 | EP2641918A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
09/25/2013 | EP2641917A2 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
09/25/2013 | EP2641891A1 Pkc- activator |
09/25/2013 | EP2641615A2 Compositions comprising dietary fat complexer and methods for their use |
09/25/2013 | EP2640381A2 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
09/25/2013 | EP2640371A1 Vasoprotective and cardioprotective antidiabetic therapy |